Perova Margarita
The United States: New Contours of the Supply Chain for Pharmaceuticals
Publication Type:

ISSN 2686-6730

DOI: 10.31857/S2686673022020079

The pandemic of COVID-19 has drawn attention to the ways in which the United States depend on critical pharmaceuticals value chains that rely on production based in China and India. China’s role as the primary supplier of APIs (active pharmaceutical ingredient) to global manufacturers of generic, highlights that the U.S. market may be dependent on China API through third markets The study of this issue implies the analysis of the main factors inducing the supply chain restructuring and also already outlined approaches to solving this problem Over the past few decades, many US pharmaceutical companies have moved finished-dose pharmaceutical production and API (active pharmaceutical ingredients) production overseas, that driven primarily by the opportunities for lower manufacturing costs and access to growing markets. The adoption of the Drug Price Competition and Patent Term Restoration Act of 1984 played an important role here. This law has opened up the market for generics. Today 90% of prescription drugs sold in the U.S. are generic medications. Despite this, generic drug sales account for less than 25% of prescription drug spending. However, there is an implicit risk in relying on elaborate global supply chains in which their provision depends on foreign partners. The Covid-19 pandemic has turned these hidden risks into real disruptions. Due to disruptions in the supply chain the United States stepped up efforts to contain the COVID-19 pandemic with limited domestic stockpiles The difficulties of 2020 forced the United States to look for options for restructuring supply chain and thus reduce this kind of dependence.

Keywords: COVID-19 pandemic | generics | U.S. dependence on provision of pharmaceuticals | API production overseas | China’s role as the primary supplier of APIs | hidden risk | disruptions in the supply chain |

Russian Science Citation Index


Mamedyarov Zaur
Strategic Role of the Pharmaceutical Industry in the Сontext of the Global Pandemic. Journal of International Analytics. 2020;11(4):122-136.

Kondrat’ev Vladimir
The role of critical raw materials in conditions of economic uncertainty: the EU experience

Mirkin Yakov
Influence of sanctions on financial risks of the russian economy

Adno Yuri
Мировая черная металлургия : кризис на пороге нового десятилетия // Черные металлы. 2020. Т. 2020, № 7. С. 51-58.

Frolov Alexander
Коронавирус форматирует проблемы безопасности // Вестник РМАТ. 2020. № 4. С. 9-17.

Pritchin Stanislav
The energy sector of the Caspian region: prospects for the development of the gas market in the new geopolitical conditions. – Geoeconomics of Energetics. № 4 (20). P.6-15.

Portansky Alexey
The pandemic is delaying solutions to the most pressing problems of global trade while creating new challenges

Arteev Sergei
COVID-19 Pandemic: Conspiracy and Anti-Conspiracy

Solyanova Maria
Пандемия COVID-19: ключевые факторы развития политики Канады в социальной сфере // Общественные науки и современность. 2021. № 6. С. 73-90. DOI 10.31857/S086904990017875-4.

Rogozhin Alexander
Electric Vehicles Production in Southeast Asia – First Success. Yugo-Vostochnaya Aziya: aktual'nyye problemy razvitiya, 2023, T. 2, № 2 (59). Pp. 57-64. DOI: 10.31696/2072-8271-2023-2-2-59057-064

Mamedyarov Zaur
Pharmaceutical Industry Development in the Midst of Crisis: Global Trends. MIR (Modernization. Innovation. Research). 2020;11(4):398-408.

Guchanova Anastasia
Здравоохранение в повестке президента Джо Байдена // Россия и Америка в XXI веке : электронный научный журнал. 2021. № 3. DOI 10.18254/S207054760016999-5. URL: . Дата публикации: 13.10.2021.

Frolov Alexander
Пандемия всколыхнула волну майданов и кризисов // Обозреватель-Observer. 2020. № 11 (370). С. 2-36.

Kopytin Ivan
Risk - Share Returns in Oil-Exporting Countries / Kopytin Ivan

Sinitsyn Mikhail
China as the Global Leader of Road Vehicle Electrification: Oil Market Risks

Terskikh Mikhail
COVID-19 Pandemic: The Vietnam Experience. Yugo-Vostochnaya Aziya: aktual'nyye problemy razvitiya, 2022, T. 1, No 1 (54). Pp. 206–214.

Kondrat’ev Vladimir
Коронавирус и горная промышленность // Горная промышленность. 2020. № 5. С. 10-18. DOI 10.30686/1609-9192-2020-3-98-104.

Arbatova Nadezhda
EU Security: Micro-Aggression with Macro-Consequences. – Polis. Political Studies. 2021. No. 5. P. 94-108. (In Russ.)

Klinova Marina
The role of State in France Economy: test for Coronavirus

Guchanova Anastasia
Evolution of American Hospitals during the COVID-19 Pandemic
Related publications

Comments (0)

No comments

Add comment

First news
Institute News

The Primakov National Research Institute of World Economy and International Relations (IMEMO) of the Russian Academy of Sciences and the Centre for Land and Warfare Studies (CLAWS) signed a Memorandum of Understanding in New Delhi.



On February 21, 2024, at 14:30 in the Academician Inozemtsev conference hall a meeting of the Scientific-Theoretical Seminar of the Center for Comparative Socio-Economic and Political Studies on the topic "Science, Religion, Society in the Dynamics of the Modern World" will be held.


Recently Published